°1èèèé§èèèSMA±é¨±èèèè·éééè70è°§°¤·è
é°è訤§èèé41°200·è·¨è¨è
¤¤°°¤è¨¤è§èè¨èèè°·
èèèè70
§è§é±é§
èé§èèèè±Spinal muscular atrophy§°SMA
SMA§èèèè訧±è§è±é·èèé§éè¨èèèééèè訰¨èèèèè駤±§è¨èè
訤éèéSMA°±¤§
¤SMA2¤¤·é¨°1:6000-1:10000è·éè¨é¨è·SAMSMA-IIIIIIIVè褧¤°SMA-I°¤
éSMAè°¤§3-5
201612¤IonisèSpinrazaèèééèFDAè·¨éSMAéè¨èèé騰èéSMAèè¨è
èè¨5qèé§èèè5qSMAèè§SMA95%
éSpinraza¨§·è餧跨SMA
20192èèé騰è§è±§°nusinersenèèèé騷697000èèè
è±nusinersen¨
è·éè¤
èèè訤°è
¤86¤é¨SMAèèèé騰é
¤è¨·è館§°è·èéèè訤¨èè°41èèé騰¨¤§è·
¤§èèThe Pharmaceutical Benefit Scheme - PBSèèé騰·èèèèéè·11èèè¨41
¤è§°è2020630èèé騰·¨¨50°è·¨40¤°è·é
·é館
è±è··°èè·è±è§è·
85°é¨é±·èèèé騰·±èèè·¨·¨
è·è訤é¤èèèèèééèèèé騰¨¤°·±é
èèé騰¨·12.5訤§75訤§37.5·é20%èè訤§é±è
¤·è·1460
觨è觰¤è
±è§¤°é±°é°è¨è¤è§èèè±°§°¤è
¤è¤è§èèè¤èé¤è§èèéèèèèè¨
¨SMA¨°¨¤§è°±è·èè¨70éèèé騰è觰¤·§SMAè·é¤
èzolgesmanusinersen
èè°±èèè±87°zolgesmaè·éè2101460°
20195FDA訧èé§èèSMA Zolgensma è¨éSMA
èèéè§éèè¨éè¨è§SMAéèè¨é
èè¨¤è§§è¨°è° 210 èèè
¤èè¨ZolgensmaSMA¨¨éè210éè°éè4094èèè4094SMAèèéèèè·210
èè¨èè¤4094è210èéè°±èèè·¨éè¨
èèé±ééè§èèèé°è¨±¤è觤èé¤
è騰
¨°.éè¨è·è¨
20191010éè§SMAèèèèé騰·¨¨¨è¨èèèè·140105¨é¨èè¨è¨¤§é¨èèèè
80%SMAèé°èé¨è¤éèè餧·èèé1-224°§¤¨¤§é¤¨
è°èèé騰¨è°¤éè·èè
èèé¨é¨èèéè¤è褨¤·èèèèé¨é¨è§èèè°é
°°éèè
觨è褧·¨éèèé§è¤§è
é¨éè§èè觰èèèè°¨èèé§è500è¨10¨è¨5000èè·¨¤5000褤
¨¤¤°°èéè°±¤è¨¤è§°èé±èè§è°
èè°è§èè訤ééè駧觰§èèèèè°é§¨è
·¨è§57§è·¤§é¨13§è§èè¨éèèèèèè13§è§è23è¨20¤§é¨éè¨è
¨¤¤¤§è¨è°è§¨è
è¤è§§±¤è§°°éè¤é褤¨¤¤è§é¨èè·è¨è§èéé·é觨èèè
è¨2019觤§°¤5§è§è2019è°°èé¨è§¨è·èè°¤éè°¤°¨
èéèèé騰§·
¤¨è¨¤èé°éè§èéè§è¨èéSMAèè§è§
20185SMAèè§
201811èèé騰è餰è
20192èèé騰éè訨è·
85駰èèé騰·èè°¤¨¤§°è§2019è°¤èé20181231è·èèèé騰20192è·2019è°¤¤2019è°¤